$IRMD News

IRADIMED CORPORATION (IRMD) Q1 2026 Earnings Call Transcript

IRADIMED (NASDAQ:IRMD) Beats Q1 Estimates, But Cautious Q2 Guidance Tempers Outlook

iRadimed Affirms FY2026 GAAP EPS Guidance of $1.90-$2.05 vs $1.91 Est

iRadimed Affirms FY2026 Adj EPS Guidance of $2.06-$2.21 vs $2.08 Est; Affirms FY2026 Sales Guidance of $91.000M-$96.000M vs $92.346M Est

iRadimed Sees Q2 GAAP EPS $0.40-$0.44 vs $0.42 Est

iRadimed Sees Q2 Adj EPS $0.44-$0.48 vs $0.47 Est; Sees Sales $20.000M-$21.000M vs $21.134M Est

iRadimed Q1 Adj. EPS $0.49 Beats $0.45 Estimate, Sales $21.979M Beat $21.315M Estimate

CEO Of iRadimed Sold $752K In Stock

Here’s What Offers IRadimed Corp. (IRMD) a Compelling Growth Trajectory

iRadimed Corp (IRMD) Q4 2025 Earnings Call Highlights: Record Revenue and Strategic Growth ...

IRadimed Corporation Q4 2025 Earnings Call Summary

iRadimed Q4 Earnings Call Highlights

iRadimed shares are trading higher after the company reported better-than-expected Q4 financial results and issued Q1 sales guidance above estimates.

iRadimed shares are trading higher after the company reported better-than-expected Q4 financial results and issued Q1 sales guidance above estimates.

IRADIMED CORP (NASDAQ:IRMD) Beats Q4 2025 Estimates and Raises Dividend

IRadimed: Q4 Earnings Snapshot

IRADIMED CORPORATION (IRMD) Q4 2025 Earnings Call Transcript

IRADIMED CORPORATION Reports Record Fourth Quarter and Full Year of 2025 Financial Results and Increases its Regular Quarterly Cash Dividend to $0.20 Per Share from $0.17 Per Share

iRadimed Raised Its Quarterly Dividend To $0.20/Share From $0.17/Share

iRadimed Sees FY2026 GAAP EPS $1.90-$2.05 vs $1.91 Est